annual CFF:
-$4.00B+$2.57B(+39.15%)Summary
- As of today (August 21, 2025), AZN annual cash flow from financing activities is -$4.00 billion, with the most recent change of +$2.57 billion (+39.15%) on December 31, 2024.
- During the last 3 years, AZN annual CFF has fallen by -$7.64 billion (-209.51%).
- AZN annual CFF is now -166.04% below its all-time high of $6.05 billion, reached on December 31, 2007.
Performance
AZN Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$501.20M+$3.21B(+118.52%)Summary
- As of today (August 21, 2025), AZN quarterly cash flow from financing activities is $501.20 million, with the most recent change of +$3.21 billion (+118.52%) on June 30, 2025.
- Over the past year, AZN quarterly CFF has increased by +$1.72 billion (+141.01%).
- AZN quarterly CFF is now -95.90% below its all-time high of $12.23 billion, reached on June 30, 2007.
Performance
AZN quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$7.01B+$1.72B(+19.74%)Summary
- As of today (August 21, 2025), AZN TTM cash flow from financing activities is -$7.01 billion, with the most recent change of +$1.72 billion (+19.74%) on June 30, 2025.
- Over the past year, AZN TTM CFF has dropped by -$4.80 billion (-216.95%).
- AZN TTM CFF is now -203.24% below its all-time high of $6.79 billion, reached on March 31, 2008.
Performance
AZN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AZN Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.1% | +141.0% | -216.9% |
| 3 y3 years | -209.5% | +138.7% | -20.9% |
| 5 y5 years | -126.4% | -55.5% | -77.8% |
AZN Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -209.5% | +41.4% | -75.3% | +112.1% | -216.9% | +19.7% |
| 5 y | 5-year | -209.5% | +41.4% | -93.1% | +112.1% | -284.5% | +19.7% |
| alltime | all time | -166.0% | +57.1% | -95.9% | +112.1% | -203.2% | +26.7% |
AZN Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $501.20M(-118.5%) | -$7.01B(-19.7%) |
| Mar 2025 | - | -$2.71B(+303.4%) | -$8.73B(+118.5%) |
| Dec 2024 | -$4.00B(-39.2%) | -$671.00M(-83.8%) | -$4.00B(+10.5%) |
| Sep 2024 | - | -$4.13B(+238.1%) | -$3.62B(+63.5%) |
| Jun 2024 | - | -$1.22B(-160.3%) | -$2.21B(-11.8%) |
| Mar 2024 | - | $2.03B(-796.9%) | -$2.51B(-61.8%) |
| Dec 2023 | -$6.57B(-3.8%) | -$291.00M(-89.3%) | -$6.57B(-1.0%) |
| Sep 2023 | - | -$2.73B(+79.5%) | -$6.63B(+24.3%) |
| Jun 2023 | - | -$1.52B(-25.2%) | -$5.34B(+4.4%) |
| Mar 2023 | - | -$2.03B(+467.3%) | -$5.11B(-25.0%) |
| Dec 2022 | -$6.82B(-287.0%) | -$358.00M(-75.0%) | -$6.82B(-7.4%) |
| Sep 2022 | - | -$1.43B(+10.4%) | -$7.37B(+27.1%) |
| Jun 2022 | - | -$1.29B(-65.4%) | -$5.79B(-307.8%) |
| Mar 2022 | - | -$3.74B(+314.6%) | $2.79B(-26.6%) |
| Dec 2021 | $3.65B(-265.6%) | -$902.00M(-735.2%) | $3.80B(+52.5%) |
| Sep 2021 | - | $142.00M(-98.1%) | $2.49B(-30.7%) |
| Jun 2021 | - | $7.29B(-366.9%) | $3.59B(-239.6%) |
| Mar 2021 | - | -$2.73B(+23.6%) | -$2.57B(+16.7%) |
| Dec 2020 | -$2.20B(+24.8%) | -$2.21B(-277.8%) | -$2.20B(<-9900.0%) |
| Sep 2020 | - | $1.24B(+10.4%) | $13.00M(-100.3%) |
| Jun 2020 | - | $1.13B(-147.7%) | -$3.94B(+15.0%) |
| Mar 2020 | - | -$2.36B(<-9900.0%) | -$3.43B(+94.3%) |
| Dec 2019 | -$1.76B(-13.6%) | $6.00M(-100.2%) | -$1.76B(-49.6%) |
| Sep 2019 | - | -$2.71B(-265.5%) | -$3.50B(+463.2%) |
| Jun 2019 | - | $1.64B(-334.8%) | -$622.00M(-70.1%) |
| Mar 2019 | - | -$698.00M(-59.7%) | -$2.08B(+1.7%) |
| Dec 2018 | -$2.04B(-30.4%) | -$1.73B(-1124.9%) | -$2.04B(+530.9%) |
| Sep 2018 | - | $169.00M(-7.1%) | -$324.00M(-90.9%) |
| Jun 2018 | - | $182.00M(-127.5%) | -$3.56B(+128.8%) |
| Mar 2018 | - | -$663.00M(+5425.0%) | -$1.56B(-47.0%) |
| Dec 2017 | -$2.94B(+121.8%) | -$12.00M(-99.6%) | -$2.94B(-9.0%) |
| Sep 2017 | - | -$3.07B(-240.3%) | -$3.23B(+175.4%) |
| Jun 2017 | - | $2.19B(-207.1%) | -$1.17B(-41.5%) |
| Mar 2017 | - | -$2.04B(+571.7%) | -$2.00B(+51.4%) |
| Dec 2016 | -$1.32B(-250.8%) | -$304.00M(-70.0%) | -$1.32B(-140.6%) |
| Sep 2016 | - | -$1.01B(-174.8%) | $3.26B(+0.1%) |
| Jun 2016 | - | $1.35B(-199.6%) | $3.26B(+56.3%) |
| Mar 2016 | - | -$1.36B(-131.8%) | $2.09B(+137.6%) |
| Dec 2015 | $878.00M(-132.5%) | $4.28B(-520.8%) | $878.00M(-138.9%) |
| Sep 2015 | - | -$1.02B(-662.4%) | -$2.25B(-10.6%) |
| Jun 2015 | - | $181.00M(-107.0%) | -$2.52B(-17.6%) |
| Mar 2015 | - | -$2.57B(-323.2%) | -$3.06B(+13.2%) |
| Dec 2014 | -$2.71B(-11.2%) | $1.15B(-189.5%) | -$2.71B(-26.3%) |
| Sep 2014 | - | -$1.29B(+259.2%) | -$3.67B(+4.8%) |
| Jun 2014 | - | -$358.00M(-83.8%) | -$3.50B(+14.6%) |
| Mar 2014 | - | -$2.21B(-1280.8%) | -$3.06B(+0.8%) |
| Dec 2013 | -$3.05B(-38.1%) | $187.33M(-116.8%) | -$3.03B(-19.6%) |
| Sep 2013 | - | -$1.12B(-1379.0%) | -$3.77B(+29.9%) |
| Jun 2013 | - | $87.43M(-104.0%) | -$2.90B(-22.5%) |
| Mar 2013 | - | -$2.19B(+298.1%) | -$3.75B(-23.9%) |
| Dec 2012 | -$4.92B(-47.2%) | -$549.78M(+119.2%) | -$4.92B(-18.2%) |
| Sep 2012 | - | -$250.85M(-66.9%) | -$6.02B(-29.7%) |
| Jun 2012 | - | -$757.14M(-77.5%) | -$8.56B(-2.1%) |
| Mar 2012 | - | -$3.37B(+105.0%) | -$8.75B(-6.0%) |
| Dec 2011 | -$9.32B | -$1.64B(-41.3%) | -$9.31B(-2.6%) |
| Sep 2011 | - | -$2.80B(+196.9%) | -$9.56B(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | -$942.00M(-76.0%) | -$8.60B(+5.9%) |
| Mar 2011 | - | -$3.93B(+107.4%) | -$8.12B(+12.2%) |
| Dec 2010 | -$7.33B(+102.1%) | -$1.89B(+3.3%) | -$7.23B(+34.9%) |
| Sep 2010 | - | -$1.83B(+296.7%) | -$5.36B(+8.8%) |
| Jun 2010 | - | -$462.35M(-84.8%) | -$4.93B(+7.1%) |
| Mar 2010 | - | -$3.04B(>+9900.0%) | -$4.60B(+25.1%) |
| Dec 2009 | -$3.63B(-43.0%) | -$24.03M(-98.3%) | -$3.68B(-30.2%) |
| Sep 2009 | - | -$1.40B(+933.2%) | -$5.27B(-12.7%) |
| Jun 2009 | - | -$135.74M(-93.6%) | -$6.04B(-1.3%) |
| Mar 2009 | - | -$2.12B(+31.1%) | -$6.12B(-4.3%) |
| Dec 2008 | -$6.36B(-205.1%) | -$1.62B(-25.6%) | -$6.39B(+30.1%) |
| Sep 2008 | - | -$2.17B(+922.5%) | -$4.92B(-13.0%) |
| Jun 2008 | - | -$212.40M(-91.1%) | -$5.65B(-183.3%) |
| Mar 2008 | - | -$2.39B(+1648.1%) | $6.79B(+11.7%) |
| Dec 2007 | $6.05B(-212.8%) | -$137.00M(-95.3%) | $6.08B(+19.2%) |
| Sep 2007 | - | -$2.91B(-123.8%) | $5.10B(-16.4%) |
| Jun 2007 | - | $12.23B(-493.7%) | $6.10B(-189.6%) |
| Mar 2007 | - | -$3.11B(+178.8%) | -$6.81B(+27.5%) |
| Dec 2006 | -$5.37B(+17.4%) | -$1.11B(-41.7%) | -$5.34B(+5.9%) |
| Sep 2006 | - | -$1.91B(+182.7%) | -$5.04B(+7.0%) |
| Jun 2006 | - | -$675.60M(-58.7%) | -$4.71B(+0.7%) |
| Mar 2006 | - | -$1.64B(+100.8%) | -$4.67B(+1.0%) |
| Dec 2005 | -$4.57B(+65.6%) | -$814.78M(-48.5%) | -$4.63B(+4.0%) |
| Sep 2005 | - | -$1.58B(+146.6%) | -$4.45B(+14.3%) |
| Jun 2005 | - | -$641.58M(-59.6%) | -$3.89B(+4.1%) |
| Mar 2005 | - | -$1.59B(+149.5%) | -$3.74B(+34.8%) |
| Dec 2004 | -$2.76B(+3.3%) | -$637.24M(-37.8%) | -$2.77B(-20.6%) |
| Sep 2004 | - | -$1.02B(+110.0%) | -$3.49B(+54.7%) |
| Jun 2004 | - | -$487.39M(-22.0%) | -$2.26B(-28.9%) |
| Mar 2004 | - | -$624.64M(-54.0%) | -$3.18B(+18.3%) |
| Dec 2003 | -$2.67B(-19.3%) | -$1.36B(-740.8%) | -$2.69B(+24.4%) |
| Sep 2003 | - | $212.00M(-115.1%) | -$2.16B(-10.9%) |
| Jun 2003 | - | -$1.41B(+957.1%) | -$2.42B(-3.5%) |
| Mar 2003 | - | -$132.96M(-84.0%) | -$2.51B(-0.1%) |
| Dec 2002 | -$3.31B(+71.2%) | -$832.53M(+1534.8%) | -$2.51B(+14.4%) |
| Sep 2002 | - | -$50.92M(-96.6%) | -$2.20B(-22.2%) |
| Jun 2002 | - | -$1.49B(+1007.1%) | -$2.82B(+8.1%) |
| Mar 2002 | - | -$135.00M(-73.9%) | -$2.61B(-1.2%) |
| Dec 2001 | -$1.94B(+383.4%) | -$516.96M(-23.7%) | -$2.64B(+20.8%) |
| Sep 2001 | - | -$677.24M(-47.2%) | -$2.19B(+38.8%) |
| Jun 2001 | - | -$1.28B(+665.9%) | -$1.58B(+276.3%) |
| Mar 2001 | - | -$167.46M(+174.9%) | -$418.93M(+4.7%) |
| Dec 2000 | -$400.29M(-75.8%) | -$60.91M(-6.8%) | -$400.29M(+17.9%) |
| Sep 2000 | - | -$65.34M(-47.8%) | -$339.38M(+23.8%) |
| Jun 2000 | - | -$125.23M(-15.8%) | -$274.04M(+84.2%) |
| Mar 2000 | - | -$148.81M | -$148.81M |
| Dec 1999 | -$1.65B(+631.0%) | - | - |
| Dec 1998 | -$226.00M(+327.2%) | - | - |
| Dec 1997 | -$52.90M(-20.8%) | - | - |
| Dec 1996 | -$66.79M(-190.0%) | - | - |
| Dec 1995 | $74.17M(-109.2%) | - | - |
| Dec 1994 | -$805.15M(-219.9%) | - | - |
| Dec 1993 | $671.56M(+638.0%) | - | - |
| Dec 1992 | $91.00M(-134.7%) | - | - |
| Dec 1991 | -$261.97M(-52.8%) | - | - |
| Dec 1990 | -$555.53M | - | - |
FAQ
- What is AstraZeneca PLC annual cash flow from financing activities?
- What is the all time high annual CFF for AstraZeneca PLC?
- What is AstraZeneca PLC annual CFF year-on-year change?
- What is AstraZeneca PLC quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly CFF year-on-year change?
- What is AstraZeneca PLC TTM cash flow from financing activities?
- What is the all time high TTM CFF for AstraZeneca PLC?
- What is AstraZeneca PLC TTM CFF year-on-year change?
What is AstraZeneca PLC annual cash flow from financing activities?
The current annual CFF of AZN is -$4.00B
What is the all time high annual CFF for AstraZeneca PLC?
AstraZeneca PLC all-time high annual cash flow from financing activities is $6.05B
What is AstraZeneca PLC annual CFF year-on-year change?
Over the past year, AZN annual cash flow from financing activities has changed by +$2.57B (+39.15%)
What is AstraZeneca PLC quarterly cash flow from financing activities?
The current quarterly CFF of AZN is $501.20M
What is the all time high quarterly CFF for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly cash flow from financing activities is $12.23B
What is AstraZeneca PLC quarterly CFF year-on-year change?
Over the past year, AZN quarterly cash flow from financing activities has changed by +$1.72B (+141.01%)
What is AstraZeneca PLC TTM cash flow from financing activities?
The current TTM CFF of AZN is -$7.01B
What is the all time high TTM CFF for AstraZeneca PLC?
AstraZeneca PLC all-time high TTM cash flow from financing activities is $6.79B
What is AstraZeneca PLC TTM CFF year-on-year change?
Over the past year, AZN TTM cash flow from financing activities has changed by -$4.80B (-216.95%)